Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for Donor Hyper Immunization
NCT02673255Phase 1Completed
- Sponsor
- Biomat USA
- Start
- Aug 2016
- Primary completion
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of tetanus toxoid in Tetanus (2 arms), sponsored by Biomat USA. Primary endpoint: Percentage of participants with a positive tetanus titer response following immunization. Started Aug 2016; status: completed.
02
Drugs
tetanus toxoid
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT02673255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673255.